Lv1
24 积分 2024-09-03 加入
Novel Highly Potent cMet Degraders against a Broad Range of Cancers
21天前
已完结
Development of highly potent and selective oncogenic KRASG12D PROTAC degraders
21天前
已完结
Novel Highly Potent c-Met Degraders against a Broad Range of Cancers
1个月前
已完结
Disrupting immune silence: Noncoding RNAs targeting the programmed cell death protein 1/programmed cell death ligand 1 axis in tumor immunity
5个月前
已关闭
Identification of 3-hydroxy-1,2-dimethylpyridine-4(1H)-thione as a metal-binding motif for the inhibition of botulinum neurotoxin A
7个月前
已完结
Bavdegalutamide (ARV-110): a potent PROTAC androgen receptor degrader for the treatment of metastatic-castration resistant prostate cancer
7个月前
已关闭
Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
7个月前
已完结
PROTAC 2.0: Expanding the frontiers of targeted protein degradation
7个月前
已完结
Targeted degradation of extracellular proteins: state of the art and diversity of degrader designs
7个月前
已完结
Progress of proteolysis-targeting chimeras (PROTACs) delivery system in tumor treatment
7个月前
已完结
皖公网安备34019202002308
